Two Randomized Controlled Trials of Ceftazidime Alone versus Ceftazidime in Combination with Trimethoprim-Sulfamethoxazole for the Treatment of Severe Melioidosis
Wirongrong Chierakul(Mahidol University), P. Chetchotisakd(Khon Kaen University), Sharon J. Peacock(John Radcliffe Hospital), Direk Limmathurotsakul(Mahidol University), Allen Cheng(Australian Regenerative Medicine Institute), Wipada Chaowagul(Sappasithiprasong Hospital), Siriluck Anunnatsiri(Khon Kaen University), Piroon Mootsikapun(Khon Kaen University), John M. Short(Mahidol University), Kasia Stepniewska(Churchill Hospital), Nicholas J. White(Angkor Hospital for Children), Bina Maharjan(Mahidol University), Andrew J. H. Simpson(University of Hull), N. P. Day(Mahidol University), Paul N. Newton(Mahidol University)
Cited by 94
Related Papers
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Complete genome sequence of a multiple drug resistant Salmonella enterica serovar Typhi CT18
|Nature|2001|1.3k
Typhoid Fever
|New England Journal of Medicine|2002|1.1k
Meticillin-resistant Staphylococcus aureus with a novel mecA homologue in human and bovine populations in the UK and Denmark: a descriptive study
|The Lancet Infectious Diseases|2011|929